Lazard Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-30,345
Closed -$394K 1134
2018
Q1
$394K Buy
+30,345
New +$394K ﹤0.01% 789